Blaze Bioscience snags $9 mln in Series B funds
Blaze Bioscience said Tuesday that it has closed $9 million in Series B financing. According to the company, the funding was provided by the firm's Series A backers and individual investors. No investors have been named. Based in Seattle, Blaze Bioscience is a biotechnology company that develops products that help improve the lives of cancer patients.
3 December 2013•3 mins read
